Sangamo said it plans to explore all options to commercialise the asset, including seeking a potential new collaboration ...

Novartis NVS announced positive top-line results from the late-stage STEER study on experimental candidate intrathecal ...

Gain Therapeutics' GT-02287 shows promise in treating Parkinson's disease, with positive results and potential for market ...

Move means small-cap won't receive an expected payout in the first quarter, creating a cash overhang Sangamo Therapeutics Inc.'s stock tumbled 53% Tuesday to put it on track for its second-biggest one ...

Sangamo Therapeutics, Inc. (NASDAQ:SGMO) regained the development and commercialization rights to giroctocogene fitelparvovec ...

Ractigen Therapeutics proudly announces that its Founder and CEO, Dr. Long-Cheng Li, has been honored with the 2024 Life Science Ice Breaking Award. This award, established by Mr. Cai Lei, a prominent ...

The newly approved medicines in 2024 from Massachusetts companies range from a schizophrenia drug to a gene therapy for ...

The results from the Phase III STEER study add to the clinical data and emerging real-world evidence for the use of one-time ...

The FDA approved an injectable version of Opdivo, a cancer drug by Bristol Myers Squibb. Axsome plans to seek approval for ...

IT has been a truly wonderful year for medicine with pioneering innovative research leading to numerous life-saving breakthroughs that will ...